[EN] DEGRADATION OF (EGFR) BY CONJUGATION OF EGFR INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE [FR] DÉGRADATION D'EGFR PAR CONJUGAISON D'INHIBITEURS D'EGFR AVEC UN LIGAND DE LIGASE E3 ET PROCÉDÉS D'UTILISATION
The present invention provides imidazopyridine compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
本发明提供了咪唑并吡啶化合物、含有该化合物的组合物,以及它们的制备方法和作为药物的使用方法。
Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same
申请人:Kim Seon Mi
公开号:US20130137661A1
公开(公告)日:2013-05-30
Disclosed are compounds useful as gonadotrophin-releasing hormone (“GnRH”) receptor antagonist.
披露了作为促性腺激素释放激素(“GnRH”)受体拮抗剂有用的化合物。
CYCLOPROPANECARBOXAMIDO-SUBSTITUTE AROMATIC COMPOUNDS AS ANTI-TUMOR AGENTS
申请人:Crown Bioscience Inc. (Taiwan)
公开号:US20150197511A1
公开(公告)日:2015-07-16
Provided are cyclopropanecarboxamido-substituted aromatic compounds that inhibit protein kinases and their use in anti-tumor area. In particular, tyrosine-kinase inhibitors and Raf-kinase inhibitors as anti-tumor agents, their preparation, pharmaceutical composition, and their use in the treatment of cancer are also provided.
Azepanes and their ring homologues having protein kinase inhibiting
申请人:Hoffmann-La Roche Inc.
公开号:US05583222A1
公开(公告)日:1996-12-10
The compounds of formula I ##STR1## wherein R.sup.1 -R.sup.9, R.sup.15, A, X, Y, Z and n have the meaning given in the specification are active as protein kinase inhibitors and can be used as medicaments, particularly for the treatment of inflammatory skin disorders and alopecia.
Probe Unit, Apparatus for Identifying Nucleotide Region and Method of Identifying Nucleotide Region
申请人:Okamoto Akimitsu
公开号:US20080302674A1
公开(公告)日:2008-12-11
A probe unit for identifying a target nucleotide region in a target nucleic acid, the unit being provided with an electrode, a probe bound to the electrode and recognizes the target nucleic acid, and a hole-transfer-inducing agent bound to the probe, wherein a nucleotide region corresponding to the target nucleotide region is located between the hole-transfer-inducing-agent-binding site and the electrode-binding end of the probe. A state of the target nucleotide region in the target nucleic acid can be identified by comparing electrochemical signal levels by energy-induced hole transfers before and after the hybridization of such a probe unit with the target nucleic acid.